Dicloxacillin

C difficile risk
Medium
Oral Bioavailability
Moderate

Dosing

250-500 mg PO q6h

General Information

Treatment of MSSA infections

  • Allergy (immediate or delayed)

  • Cytopenias

  • Eosinophilia

  • Interstitial nephritis

  • Abnormal liver enzymes

  • Phlebitis at injection site in a peripheral vein

Warfarin: Can DECREASE INR

Can increase methotrexate levels.

Decrease mycophenolate levels.

Tetracyclines can diminish dicloxacillin activity.

Antimicrobial class: Antistaphylococcal Penicillin

Pregnancy category: B

Average serum half life: 1 hour

Biliary penetration: Moderate

Lung penetration: Therapeutic

Urine penetration: Therapeutic

Route of Elimination: Feces and urine

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.